Furthermore, we recently demonstrated that AT1R was expressed in gynaecological malignancies, including cervical cancer (Kikkawa et al, 2004), endometrial cancer (Watanabe et al, 2003), choriocarcinoma (Ino et al, 2003), and ovarian cancer (Suganuma et al, 2005). This evidence concerns the gene AGTR1 and ovarian carcinoma.